[1] |
Houghton AM. The paradox of tumor-associated neutrophils: fueling tumor growth with cytotoxic substances[J]. Cell Cycle, 20 10, 9(9): 1732-7.
|
[2] |
Bekes EM, Schweighofer B, Kupriyanova TA, et al. Tumorrecruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation[J]. Am J Pathol, 2011, 179(3): 14 55-70.
|
[3] |
Sun R, Luo J, Li D, et al. Neutrophils with protumor potential could efficiently suppress tumor growth after cytokine priming and in presence of normal NK cells[J]. Oncotarget, 2014, 5(24): 12 621-34.
|
[4] |
Scherzad A, Steber M, Gehrke T, et al. Human mesenchymal stem cells enhance cancer cell proliferation via IL-6 secretion and activation of ERK1/2[J]. Int J Oncol, 2015, 47(1): 391-7.
|
[5] |
Sen M, Pollock NI, Black J, et al. JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth[J]. Neoplasia, 2015, 17(3): 256-64.
|
[6] |
Schröer N, Pahne J, Walch B, et al. Molecular pathobiology of human cervical high-grade lesions: paracrine STAT3 activation in tumor-instructed myeloid cells drives local MMP-9 expression[J]. Cancer Res, 2011, 71(1): 87-97.
|
[7] |
Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment[J]. Cell, 2010, 141(1): 52 -67.
|
[8] |
Nozawa H, Chiu C, Hanahan D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis[J]. Proc Natl Acad Sci U S A, 2006, 103(33): 12 493-8.
|
[9] |
Wang Y, Wang K, Han GC, et al. Neutrophil infiltration favors colitis-associated tumorigenesis by activating the interleukin-1 (IL-1)/IL-6 axis[J]. Mucosal Immunol, 2014, 7(5): 1106-15.
|
[10] |
Nikakhlagh S, Ranjbari N, Khorami E, et al. Association between Serum Levels of Interleukin-6 and Stage of Laryngeal Cancer[J]. Iran J Otorhinolaryngol, 2015, 27(80): 199-205.
|
[11] |
Fielding CA, McLoughlin RM, McLeod L, et al. IL-6 regulates neutrophil trafficking during acute inflammation via STAT3[J]. J Immunol, 2008, 181(3): 2189-95.
|
[12] |
Tkach M, Coria L, Rosemblit C, et al. Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells[J]. J Immunol, 2012, 189(3): 1162-72.
|
[13] |
Yan B, Wei JJ, Yuan Y, et al. IL-6 cooperates with G-CSF to induce protumor function of neutrophils in bone marrow by enhancing STAT3 activation[J]. J Immunol, 2013, 190(11): 5882-93.
|